German China
Astrazeneca has recently announced 50 billion dollars of investment in the United States by 2030, building on America’s global leadership in medicines manufacturing and R&D.  (Source: Astrazeneca)
Medicine Production

Astrazeneca to Invest 50 Billion Dollars in the USA

With a mega investment of 50 billion dollars, Astrazeneca has plans to expand its presence in medicines manufacturing and R&D in the USA. The company intends to set up a new multi-billion-dollar manufacturing facility in the country which is expected to produce drug substances for the Company’s innovative weight management and metabolic portfolio.

Read on
Kobe University bioengineers came up with a new way of automatically grouping large numbers of enzymes in a way that makes it easy to select a set of meaningful representatives and focus research on these. (Source: Hidese Ryota)
From Data to Discovery

New Robotic Method Unearths Super-Enzyme for Green Chemistry

Hasunuma Tomohisa and his team developed a workflow that allows them to screen a large variety of enzymes for a given function and tried it on a class of almost 7000 enzymes that are involved in a process needed to produce the raw materials for fuels, plastics and flavors. The Kobe University team now reports that this approach allowed them to identify an enzyme that has a productivity up to ten times higher than that of the current industry standard.

Read on